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Abstract  
The age-associated reduction in muscle mass is well characterised, however less is known 
regarding the mechanisms responsible for the decline in oxidative capacity also observed 
with advancing age. The purpose of the current study was therefore to compare mitochondrial 
gene expression and protein content between young and old recreationally active, and older 
highly active individuals. Muscle biopsies were obtained from the vastus lateralis of young 
males (YG: 22±3 years) and older (OG: 67±2 years) males not previously engaged in formal 
exercise and older male master cyclists (OT: 65±5 years) who had undertaken cycling 
exercise for 32±17 yrs. Comparison of gene expression between YG, OG and OT groups 
revealed greater expression of mitochondrial-related genes, namely electron transport chain 
(ETC) complexes II, III, IV (p<.05) in OT compared to YG and OG. Gene expression of 
mitofusion (MFN)-1/2, mitochondrial fusion genes, were greater in OT compared to OG 
(p<.05). Similarly, protein content of ETC complexes I, II and IV were significantly greater 
in OT compared to both YG and OG (p<.001). Protein content of peroxisome proliferator-
activated receptor gamma, coactivator 1 α (PGC-1α), was greater in OT compared to YG and 
OG (p<.001). Our results suggest that the aging process per se, is not associated with a 
decline in gene expression and protein content of ETC complexes. Mitochondrial-related 
gene expression and protein content is substantially greater in OT, suggesting that exercise-
mediated increases in mitochondrial content can be maintained into later life. 
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Running title: Markers of mitochondrial biology are enhanced in master athletes 
Introduction 
Skeletal muscles of most older individuals are characterized by several adverse 
morphological changes1-4, a phenotype directly influenced by physical activity 5-7. Some groups 
report an age-associated decline in fibre cross sectional area in sprint-trained older individuals8 
whereas this association is not observed in highly trained master cyclists6. This observation therefore 
questions the extent to which these adverse changes to skeletal muscle health are a function of the 
aging process or the interaction with age and physical inactivity8. 
Considerable attention has been given to determining the effects of aging on mitochondrial 
function in skeletal muscle9. In addition to being associated with a decline in muscle fatigue 
resistance, aberrant mitochondrial function is proposed as a major contributor to sarcopenia10. In 
support of this motion, previous research has reported an age-associated decline in mtDNA11, in 
addition to a reduction in gene expression of mitochondrial transport chain subunits12. The 
reduction in mitochondrial related gene expression translates to the decline in mitochondrial related 
protein content observed with aging11, although this apparent reduction is not observed in middle-
aged adults where protein content of electron transport chain (ETC) complex I is greater when 
compared to young13. In addition, aging is associated  with an increase in mtDNA mutation-
deletions14, an increase in oxidative damage12 and altered protein content of factors involved in 
mitochondrial dynamics15. These findings however are not universal, as other groups have reported 
that aging had no effect on mitochondrial associated gene networks16, mitochondrial respiration and 
protein content of ETC subunits19 and regulators of mitochondrial dynamics17. Contrasting results 
may be due to a number of factors, one of which may be the physical activity status of old 
individuals included in these studies. For example, Disteffano and colleagues recently demonstrated 
that cardiorespiratory fitness has a greater influence on mitochondrial respiration than age17. 
Although sedentary aging is associated with a variety of metabolic perturbations, it is suggested that 
these may be related to the low levels of physical activity rather than to the aging process per se6. Or 
alternatively, physical activity remains beneficial even in advancing age. This latter notion is 
supported by studies demonstrating that older athletes, when compared to sedentary counterparts, 
have greater mitochondrial content, function20, gene expression of ETC subunits19, and protein 
content related to mitochondrial dynamics17. In older individuals, mitochondrial volume density is 
correlated with exercise capacity suggesting a role for physical activity to maintain mitochondrial 
content in this population21. Importantly, older individuals retain the ability to positively respond to 
aerobic exercise training21,22, placing regular physical exercise as an effective measure for improving 
mitochondrial content and function throughout the lifespan.  
Several studies have sought to characterize the differences in gene and protein expression 
between either young and sedentary older adults or older sedentary and older athletes. However, 
few have examined the differences between young and old recreationally active and old highly 
active master athletes, thereby allowing the combined comparison of age and physical activity 
levels. Therefore, the purpose of the current study was to compare mitochondrial-related gene 
expression and protein abundance in the quadriceps muscle between recreationally active young 
(YG), old individuals who were healthy, but did not undertake regular exercise (OG) and older 
individuals who had been highly active through cycling exercise for many years (OT). We determined 
whether genes and proteins related to whole muscle metabolism, mitochondrial biogenesis, 
dynamics and mitophagy were differentially expressed between groups to further characterize the 
aging muscle phenotype and the impact of physical activity.  
Methods 
Ethical Approval. 
Prior to participation written informed consent was obtained from all subjects. Procedures were 
approved by the National Health Service Wandsworth Research Ethics Committee (reference 
number 12/LO/0457) and the University of Nottingham Faculty of Medicine and Health Science 
Research Ethics Committee (B/10/2010), with all procedures conforming to the Declaration of 
Helsinki. All human tissue collected, stored and analysed was done so in accordance with the Human 
Tissue Act. 
Participants. 
The OT group is a subset from a large cross-sectional study previously described by Pollock et al. 
(2015) in which the physiological function of a group of amateur non-elite cyclists aged 55-79 years 
was evaluated23. The inclusion criteria of males was the ability to cycle 100 km in under 6.5h and 
subjects were required to have undertaken this task twice in the 3 weeks prior to testing20. Subjects 
included in the OG group (672years; 272.8kg/m2; n=8, for subsequent gene expression and 
protein content analysis) were selected to have similar ages and body mass index (BMI) to those of 
the OT group (655years; 25.92.1kg/m2; n=7, for subsequent gene expression analysis, n=8 for 
subsequent protein content analysis). Subjects included in the YG group (213years; 23.92.5 kg/m2; 
n=6, for subsequent gene expression analysis, n=9 for subsequent protein content analysis) were 
selected to best match BMI from the older groups.  Both YG and OG were recreationally active and 
performed activities of daily living but none were involved in a formal exercise training programme 
nor did they participate in more than 2 sessions of purposeful exercise each week. No differences 
between BMI are observed between groups and no differences between ages are observed between 
the OT and OG groups. Due to lack of tissue the sample size was smaller for gene expression analysis 
as stated above. 
 
Muscle biopsy sampling. 
Following administration of local anaesthetic (1% lidocaine for the YG and OG; 2% lidocaine for the 
OT) a muscle sample was obtained from the vastus lateralis of all participants using the conchotome 
technique24 for the YG and OG groups and the Bergstrom needle technique with applied suction for 
the OT group6. All participants in the YG and OG groups were instructed not to exercise for 72h prior 
to their biopsy which was taken after an overnight fast (~12 h) with water ad libitum. Participants in 
the OT group were asked to maintain habitual levels of physical activity the day prior to their biopsy. 
RNA isolation and Reverse Transcription 
RNA was isolated from 15 – 20 mg of powdered muscle tissue using TRI Reagent/ReliaPrep spin 
columns. Briefly, all samples were homogenized in 1ml of TRI Reagent (Sigma Aldrich, Gillingham, 
UK) with the FastPrep 24 5G (MP Biomedicals, Santa Ana, California, USA) at a speed of 6 m/s for 40 
seconds. 200ul of chloroform was added to each sample and mixed vigorously for 15 sec then 
incubated at room temperature for 5 min, then centrifuged at 12000g for 10 min at 4°C. The RNA 
(aqueous phase) was purified using Reliaprep spin columns (Promega, Madison, Wisconsin, USA) as 
per manufacturer’s instructions. RNA concentrations were determined using the LVis function of the 
FLUOstar Omega microplate reader. RNA was diluted to 20 g/L and reverse transcribed to cDNA 
using the RT2 First Strand kit (Qiagen, Manchester, UK). 
Quantitative RT-PCR 
Quantitative analysis of 84 genes was completed using custom designed 384-well RT2 PCR Profiler 
Array (Qiagen) and RT2 SYBR Green Mastermix (Qiagen) on a CFX384 Real-Time PCR Detection 
System following manufacturer’s instructions (Bio-Rad). Briefly, 2.8 ng of cDNA was added to each 
well. The absence of genomic DNA, the efficiency of reverse-transcription and the efficiency of the 
PCR assay were assessed on each plate and conformed to the manufacturer’s limits in each case. The 
C(t) values for housekeeper genes beta actin (Refseq# NM_001101), heat shock protein 90 (Refseq# 
 
NM_007355) and beta-2-microglobulin (Refseq# NM_004048) showed no statistical differences 
between groups. Therefore, the geometric mean C(t) of all three housekeeper genes was used as an 
internal control23. Statistical analysis was carried out on the C(t) (C(t) gene of interest - C(t) 
mean of gene of interest of the YG). Data is presented as a fold change from YG as determined using 
the 2-C(t) method2627. 
Immunoblotting 
Approximately 25mg of powdered muscle tissue was homogenized in 300 ul of ice-cold sucrose lysis 
buffer (50 mM Tris, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 5 mM Na4P2O7-10H2O, 270 mM sucrose, 1 
M Triton-X, 25 mM -glycerophosphate, 1 M Trichostatin A, 10 mM Nicatinamide, 1mM 1,4-
Dithiothreitol, 1% Phosphatase Inhibitor Cocktail 2; Sigma, 1% Sigma Phosphatase Inhibitor Cocktail 
2; Sigma, 4.8% cOmplete Mini Protease Inhibitor Cocktail; Roche) using the FastPrep 24 5G (MP 
Biomedicals, Santa Ana, California, USA) at a speed of 6 m/s for 40 seconds and repeated 3 times. 
Samples were then centrifuged at 4°C at a speed of 8000 g for 10 minutes to remove insoluble 
material. Protein content was determined from the DC protein assay (Bio-Rad, Hercules, California, 
USA) using FLUOstar Omega at an absorbance of 750nm). Laemmli samples buffer was added and 
samples were boiled for 5 minutes, equal amounts of protein (20-50 ug) was separated by SDS-PAGE 
on 8 – 12.5% gels at a constant current of 23 mA per gel. Proteins were transferred to BioTrace NT 
nitrocellulose membranes (Pall Life Sciences, Pensacola, Florida, USA) via wet transfer at 100 V for 
one hour on ice. Membranes were stained with Ponceau S (Sigma-Aldrich, Gillingham, UK) and 
imaged to assure even loading and for future normalization. Membranes were blocked in 3% dry-
milk in tris-buffered saline with tween (TBST) for one hour prior to an overnight primary antibody 
incubation at 4°C. Membranes were washed in TBST three times prior to incubation in appropriate 
horse radish peroxidase-conjugated secondary antibody at room temperature for one hour. 
Membranes were then washed in TBST three times prior to antibody detection via enhanced 
chemiluminescence horseradish peroxidase substrate detection kit (Millipore, Watford, UK). Imaging 
and band quantification were undertaken using a G:Box Chemi-XR5 (Syngene, Cambridge, UK). Mean 
pixel intensity was determined for each band. All bands were normalized to a gel control in addition 
to the corresponding ponceau image. Statistical analysis was carried out on normalized values for 
each protein of interest. 
Antibodies 
All primary antibodies were prepared in TBST. Antibodies used were as follows: total OXPHOS 
human WB antibody cocktail (ab11041; abcam, 1:1000 in unboiled samples), PGC-1Antibody 
(AB3242; Merck, 1:1000), pyruvate dehydrogenase antibody (PDH; #2784; Cell signalling technology, 
1:1000), Citrate synthase (SAB2701077; MitoSciences, 1:1000), Sirtuin3 (SirT3 D22A3; Cell signalling 
technology, 1:1000). Very long chain acyl CoA dehydrogenase (VLCAD; 1:5000), long chain acyl CoA 
dehydrogenase (LCAD; 1:5000), medium chain acyl-CoA dehydrogenase (MCAD; 1:5000), were kind 
gifts from Prof Jerry Vockley, University of Pittsburgh, USA. Appropriate secondary antibodies either 
anti-rabbit (7074) or anti-mouse (7076) from Cell Signaling Technology were used at a concentration 
of 1:10000 in TBST. 
Statistical Analysis 
Statistical analysis was performed using Prism 7 (GraphPad Software Incorporated). To assess 
differences between YG, OG and OT groups a one-way analysis of variance (ANOVA) was completed 
on individual genes and proteins independently, multiple comparisons were assessed using Tukey’s 
test. The normal distribution of data was verified using the Shapiro-Wilk normality test. Values are 
presented as mean ± standard deviation. 
Results 
Mitochondrial related genes expression profile is altered in master athletes 
The mRNA expression of 84 target genes was assessed in YG (n=6), OG (n=8) and OT (n=7) groups, 
gene expression is presented as a fold change from the YG group (Supplemental Table 1). Of the 84 
genes assessed 23 were differentially expressed (p<.05) (Supplemental Table 1). Differentially 
expressed genes of mitochondrial related proteins and transcriptional regulators are presented in 
Figure 1. Differentially expressed genes related to skeletal muscle structural remodelling are 
presented in Figure 2. Differentially expressed genes related to substrate metabolism are presented 
in Figure 3.  
Mitochondrial related protein content. 
Protein content was assessed in YG (n=9), OG (n=8) and OT (n=8). Protein content of each complex 
of the electron transport chain was assessed via immunoblotting. There was no difference between 
YG and OG for any protein assessed. Protein content of complex I, II and IV were 7.1-, 1.9- and 1.3-
fold greater in OT compared to OG and 5.6-, 2.1- and 1.2-fold greater compared to YG (p<.05) (Fig 
4a). There are no differences in protein content of complex III and V across groups (p>.05). Protein 
content of PGC-1α was 2.9-fold greater in OT compared to OG (p<.05) and 5.4-fold greater 
compared to YG (p<.001) (Fig 4b). Protein content of CS was 1.9-fold greater in the OT compared to 
both the OG (p<.001) and 1.3-fold greater in the OT compared to the YG (p<.001) (Fig 4c). 
Additionally, protein content of SIRT3 was 1.8-fold greater in OT compared to both OG (p<.001) and 
to YG (p≤.001) (Fig 4d).  
Protein content related to substrate metabolism. 
Protein content of pyruvate dehydrogenase (PDH), LCAD and MCAD was 3-, 1.8- and 1.6-fold 
greater, respectively in OT compared to OG and 2.8-, 1.9- and 2.1-fold greater, respectively, 
compared to YG (p<.05) (Fig 5a,b,c). Protein content of VLCAD was 1.7-fold greater in OT compared 
to OG (p<.05) (Fig 5d).  
Discussion 
Many studies have sought to determine the effect of aging on mitochondrial content and 
function11-15,17-19, however few have accounted for the divergent levels of physical activity in the 
older population. Here we have directly compared young and old recreationally active adults in 
addition to old highly aerobically trained (master cyclists) adults. The inclusion of these three distinct 
groups allows the effects of activity to be established and therefore what extent declines in function 
can be attributed to chronological aging8. The primary finding of this study is that highly active older 
adults, have greater mitochondrial related protein content and gene expression in comparison to 
recreationally active untrained young and older adults. Importantly, no observable age-associated 
reduction in mitochondrial related protein content and gene expression (except for CS mRNA 
expression) was observed in the recreationally active older group in which the negative effects of 
inactivity are eliminated. In addition, we report no change in OXPHOS, PGC-1α or mitochondrial 
fusion and fission-related gene expression with age.  
Previous work has described a reduction in mtDNA, mitochondrial protein content and ATP 
production in older adults who had similar physical activity levels to young counterparts (<30 mins, 
<2 days/week)11. However more recent work suggests that mitochondrial related protein content 
may not be affected by aging17. Our results are in line with the latter in which chronological age does 
not impact mitochondrial related protein content (Fig 4a). A lower expression in OG compared to YG 
is only observed with respect to CS (Fig 1c) and UQCRC1 (Fig 1d) gene expression. However, this was 
not observed at the protein level (Fig 4c). Although chronological aging per se did not impact 
mitochondrial related protein content and gene expression in our hands, the impact of high levels of 
physical activity in advanced age was substantial. We report greater expression of genes related to 
the electron transport chain (SDHA, SDHB, UQCRC1, UQCRC2 and COX4I2) in the OT compared to 
both the YG and OG groups (Fig 1). These results are supported by greater protein content of 
complex I, II and IV of the electron transport chain in the OT compared to YG and OG groups (Fig 4a). 
Larsen and co-workers have reported an association between protein content of complex II and V 
and total mitochondrial content measured via mitochondrial volume by transmission electron 
microscopy29. Although not a direct measure of mitochondrial content, our results are in accordance 
with previous work demonstrating a greater mitochondrial volume density and content of ETC 
proteins in old active compared to sedentary adults20,21. Given that endurance exercise training is 
well established as a potent activator of mitochondrial biogenesis30, the greater mitochondrial 
related gene expression and protein content in the OT group is likely due to their high physical 
activity levels and the metabolic demands placed on skeletal muscle.  
In addition, we report greater PGC-1α gene expression in the OT compared to the OG group 
(Fig 1b) and greater PGC-1α protein content in OT compared to both the YG and OG groups (Fig 4b). 
These results are in partial contrast with previous work reporting a reduction in PGC-1α protein 
content with aging in both ‘high’ and ‘low’ functioning sedentary older adults28. As PGC-1α is an 
important regulatory signalling node for the initiation of mitochondrial biogenesis, a greater 
expression in the OT group may reflect a greater mitochondrial mass due to greater habitual physical 
activity levels in this cohort. Thus, our results suggest that mitochondrial biogenesis is primarily 
affected by activity status rather than aging. PGC-1 α also regulates the gene expression of SIRT331, a 
NAD+-dependent deacetylase highly involved in metabolism32. Accordingly, we report greater 
expression (Fig 1a) and protein content (Fig 4d) of SIRT3, in the OT group compared to both the YG 
and the OG groups. Again, this observation suggests that aging per se is not associated with a 
reduction in markers of mitochondrial metabolism; rather that exercise training has a positive effect 
on SIRT3 induction irrespective of age.  
Skeletal muscle mitochondrial function is believed, in part, to be regulated by the tumour 
suppressor p5335. Here we demonstrate that gene expression of p53 targets, SESN2 and PMPAIP1, 
are increased in the OT group although not affected by aging (Fig 2). ZMAT3 another target of p53, 
has a greater expression in both OG and OT (Fig 2g,h). Interestingly, no change in p53 expression 
was observed between groups (p>.05) (Supplemental Table 1). With the design of the current study 
we are unable to state whether the increase in p53 target genes are beneficial or detrimental in 
maintaining muscle health.  
Information regarding content of proteins involved in mitochondrial dynamics in aging 
skeletal muscle are equivocal with some reports indicating either no change or a reduction15,17,28.
Recently, Tezze et al.(2017), have reported greater expression of OPA1, MFN1/2 and DRP1 in “older 
sportsmen” and young individuals compared to old inactive individuals15. Balan et al. (2019) report 
greater mitochondrial protein content of MFN2 and OPA1 in active young and older adults in 
comparison to sedentary age-matched subjects however, they do not observe an age-associated 
reduction in protein content19. This is partially confirmed by our findings where expression of MFN1 
and MFN2, were greater in OT compared to OG, however, in our hands aging did not result in a 
reduced expression (Fig 2e,f). This may relate to possible differences in the activity status of the 
recreational active older participants in the present study and the “sedentary seniors” in the study of 
Tezze et al. (2017)15. Additionally, we did not observe differences in expression of other genes 
related to mitochondrial dynamics, such as OPA1 and FIS1 (Supplemental Table 1). Our results 
suggest that aging does not impair the dynamic remodelling of the mitochondrial reticulum but 
highly active older adults may require enhanced mitochondrial remodelling to support the stresses 
placed on the skeletal muscle as evidenced by greater gene expression of MFN1/2. 
Although we report very few changes associated with chronological aging with respect to 
protein and gene expression, it is important to note that skeletal muscle of older individuals remains 
a highly plastic tissue and responds positively to exercise training37-41. Although, older individuals’ 
response to resistance exercise training may be attenuated in comparison to young adults, they are 
able to increase muscle fibre size41. In line with this, endurance exercise training in older individuals’ 
results in improved maximal oxygen uptake, mitochondrial enzyme activities, and increase in muscle 
fibre size42-44. Importantly, a recent analysis of cross-sectional data demonstrates that when older 
adults commence intense training and competition in later life (>50y), no differences are observed 
with respect to performance and body composition (fat mass and leg lean mass) compared to adults 
having trained their entire adult life22. Thus, further highlighting the ability of older individuals to 
positively respond to exercise.  
One of the limitations of the present study was the lack of precise quantification of levels of 
physical activity in the groups that described themselves as being recreationally active. It is likely 
however, that the OG did not reflect the majority of older people who are known to engage in 
reduced levels of physical activity46. Thus, comparison with the OT group is, if anything, most likely to 
be an underestimate of the differences in phenotype between lifelong exercisers and most of the 
older population.  
In summary, we observed greater mitochondrial related gene expression and protein 
content in highly active older individuals compared to young and aged-matched recreationally active 
individuals. Chronological aging in recreationally active individuals, did not affect mitochondrial 
related gene and protein expression. Collectively these data suggests that high levels of physical 
activity, even in advancing age, results in greater mitochondrial-related gene expression and protein 
content compared to young and age matched untrained individuals. Further, our results highlight 
that chronological aging does not result in a reduction in mitochondrial content and function and 
supports the notion that skeletal muscle retains the ability to positively respond to stimuli even in 
advancing age.  
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Figure Captions 
Fig. 1 Mitochondrial related gene expression is greater in highly active older individuals. mRNA of 
genes related to mitochondrial content in recreationally active young (YG n=6; black bars), old 
individuals who were healthy, but did not undertake regular exercise (OG n=8; grey bars), older 
individuals who had been highly active through cycling exercise for many years (OT n=7; open bars). 
Data are presented as a fold change from YG. (a) sirtuin 3 (SIRT3) (b) peroxisome proliferator-
activated receptor gamma, coactivator 1 alpha (PGC-1α) (c) citrate synthase (CS) (d) ubiquinol-
cytochrome c reductase core protein I (UQCRC1) (e) ubiquinol-cytochrome c reductase core protein 
II (UQCRC2) (f) cytochrome c oxidase subunit IV isoform 1 (COX4I2) (g) cytochrome c oxidase 
assembly homolog 10 (COX10) (h) succinate dehydrogenase complex, subunit A, flavoprotein (SDHA) 
(i) succinate dehydrogenase complex, subunit B, iron sulfur (SDHB) (j) translocase of inner
mitochondrial membrane 8 homolog A (TIMM8A).  a significantly different from YG, b significantly 
different from OG. 
Fig. 2 Skeletal muscle related gene expression is greater in highly active older individuals. mRNA 
expression of genes related to skeletal muscle remodelling in recreationally active young (YG n=6; 
black bars), old individuals who were healthy, but did not undertake regular exercise (OG n=8; grey 
bars), older individuals who had been highly active through cycling exercise for many years (OT n=7; 
open bars). Data are presented as a fold change from YG. (a) vascular endothelial growth factor A 
(VEGFA) (b) vascular endothelial growth factor B (VEGFB) (c) myogenic differentiation 1 (MyoD1) (d) 
BTG family, member 2 (BTG2) (e) mitofusin 1 (MFN1) (f) mitofusin 2 (MFN2) (g) sestrin 2 (SESN2) (h) 
phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1) (i) zinc finger, matrin-type 3 (ZMAT3).  
a significantly different from YG OG, b significantly different from OG. 
Fig. 3 Substrate metabolism related gene expression is greater in highly active older individuals. 
mRNA expression of genes related to substrate metabolism in recreationally active young (YG n=6; 
black bars), old individuals who were healthy, but did not undertake regular exercise (OG n=8; grey 
bars), older individuals who had been highly active through cycling exercise for many years (OT n=7; 
open bars). Data are presented as a fold change from YG. (a) isocitrate dehydrogenase 2 (NADP+) 
(IDH2) (b) malate dehydrogenase 1, NAD (MDH1) (c) pyruvate dehydrogenase kinase, isozyme 4 
(PDK4) (d) nuclear receptor subfamily 1, group D, member 2 (NR1D2).  a significantly different from 
YG OG, b significantly different from OG. 
Fig. 4 Mitochondrial related protein content is greater in highly active older individuals.  Protein 
content in recreationally active young (YG n=9; black bars), old individuals who were healthy, but did 
not undertake regular exercise (OG n=8; grey bars), older individuals who had been highly active 
through cycling exercise for many years (OT n=8; open bars). (a) Protein content of mitochondrial 
enzymes (complexes I-V), (b) peroxisome proliferator-activated receptor gamma, coactivator 1 alpha 
(PGC-1α), (c) citrate synthase (CS) and (d) sirtuin 3 (SIRT3). (e) Representative images of protein 
content of mitochondrial enzymes (complexes I-V), PGC-1α, CS and SIRT3 in YG, OG and OT. All 
values were normalized to their respective ponceau stain. Data are presented as mean ± standard 
deviation. b significantly different from OG and YG 
Fig. 5 Substrate metabolism related protein content is greater in highly active older individuals. 
Protein content in recreationally active young (YG n=9; black bars), old individuals who were healthy, 
but did not undertake regular exercise (OG n=8; grey bars), older individuals who had been highly 
active through cycling exercise for many years (OT n=8; open bars). (a) protein content of pyruvate 
dehydrogenase (PDH), (b) long chain acyl CoA dehydrogenase (LCAD), (c) medium chain acyl-CoA 
dehydrogenase (MCAD), and (d) very long chain acyl CoA dehydrogenase (VLCAD). (e) 
Representative images of protein content of PDH, LCAD, MCAD and VLCAD. All values were 
normalized to their respective ponceau stain. Data are presented as mean ± standard deviation. a 
significantly different from OG, b significantly different from OG and YG    
eTable 1. mRNA expression of genes included on the designed RT2 Profiler PCR 
Array.  
Name Abbreviation Refseq # YG OG OT 
sirtuin 1 SIRT1 NM_001142498 1.00 1.11 1.13 
sirtuin 3 SIRT3 NM_001017524 1.00 1.04 1.53 (c) 
sirtuin 6 SIRT6 NM_001193285 1.00 1.04 1.36 
transcription factor A, 
mitochondrial 
TFAM NM_003201 1.00 0.85 1.05 
transcription factor B1, 
mitochondrial 
TFB1M NM_016020 1.00 0.96 1.22 
transcription factor B2, 
mitochondrial 
TFB2M NM_022366 1.00 1.15 1.19 
vascular endothelial 
growth factor A 
VEGFA NM_001025366 1.00 1.08 2.04 (b) 
vascular endothelial 
growth factor B 
VEGFB NM_001243733 1.00 0.92 1.32 (a) 
vascular endothelial 
growth factor C 
VEGFC NM_005429 1.00 1.00 1.64 
BCL2-associated agonist 
of cell death 
BAD NM_004322, 
NM_032989 
1.00 0.81 0.99 









1.00 1.03 1.12 
BCL2 binding component 
3 
BBC3 NM_001127240 1.00 1.36 0.98 




CASP9 NM_001229 1.00 1.14 0.98 
Fas cell surface death 
receptor 
FAS NM_000043 1.00 0.81 0.62 
phorbol-12-myristate-13-
acetate-induced protein 1 
PMAIP1 NM_021127 1.00 1.66 3.30 (b) 
zinc finger, matrin-type 3 ZMAT3 NM_152240 1.00 1.28 (c) 1.30 (c) 
breast cancer 1, early 
onset 
BRCA1 NM_007294 1.00 1.02 1.25 
epidermal growth factor 
receptor 
EGFR NM_005228 1.00 1.00 0.83 
growth arrest and DNA-
damage-inducible, alpha 
GADD45A NM_001199741 1.00 0.87 1.01 
proliferating cell nuclear 
antigen 
PCNA NM_002592 1.00 0.99 1.05 
pituitary tumor-
transforming 1 
PTTG1 NM_004219 1.00 1.55 1.41 
retinoblastoma 1 RB1 NM_000321 1.00 0.95 0.98 
sestrin 2 SESN2 NM_031459 1.00 1.42 2.09 (c) 
beclin 1, autophagy 
related 
BECN1 NM_003766 1.00 0.93 1.00 
Name Abbreviation Refseq # YG OG OT 









1.00 1.01 1.15 
BCL2/adenovirus E1B 
19kDa interacting protein 
3 














MYC NM_002467 1.00 1.03 0.78 
cytochrome c oxidase 
assembly homolog 10 
(yeast) 
COX10 § NM_001303 1.00 0.75 1.05 
COX18 cytochrome C 
oxidase assembly factor 
COX18 NM_001033760 1.00 0.99 1.41 
fission 1 (mitochondrial 
outer membrane) 
homolog (S. cerevisiae) 
FIS1 NM_016068 1.00 0.86 1.03 
mitofusin 1 MFN1 NM_017927 1.00 0.88 1.12 (a) 
mitofusin 2 MFN2 NM_001127660 1.00 0.97 1.48 (a) 
optic atrophy 1 
(autosomal dominant) 
OPA1 NM_015560 1.00 0.96 1.16 
translocase of outer 
mitochondrial membrane 
20 homolog (yeast) 
TOMM20 NM_014765 1.00 0.89 0.92 
translocase of outer 
mitochondrial membrane 
22 homolog (yeast) 
TOMM22 NM_020243 1.00 0.92 0.99 
translocase of inner 
mitochondrial membrane 
8 homolog A (yeast) 
TIMM8A NM_001145951 1.00 0.82 1.55 (a) 
translocase of inner 
mitochondrial membrane 
9 homolog (yeast) 
TIMM9 NM_012460 1.00 0.73 0.96 
peroxisome proliferator-
activated receptor 
gamma, coactivator 1 
alpha 
PGC-1α NM_013261 1.00 0.73 1.42 (a) 
peroxisome proliferator-
activated receptor 




1.00 0.78 1.30 
citrate synthase CS NM_004077 1.00 0.77 (d) 1.28 
hexokinase 2 HK2 NM_000189 1.00 1.53 2.50 
pyruvate dehydrogenase 
kinase, isozyme 4 
PDK4 NM_002612 1.00 2.88 0.43 (a) 
solute carrier family 2 
(facilitated glucose 
transporter), member 4 
SLC2A4 NM_001042 1.00 0.94 1.22 
Name Abbreviation Refseq # YG OG OT 
myogenic differentiation 1 MYOD1 NM_002478 1.00 0.82 1.73 (b) 
histone deacetylase 3 HDAC3 NM_003883 1.00 0.99 0.96 
histone deacetylase 5 HDAC5 NM_001015053 1.00 1.22 1.19 
peroxisome proliferator-
activated receptor alpha 
PPARA NM_001001928 1.00 1.06 1.29 
peroxisome proliferator-
activated receptor delta 
PPARD NM_001171818 1.00 0.70 0.86 
NADH dehydrogenase 
(ubiquinone) 1 alpha 
subcomplex, 1, 7.5kDa 
NDUFA1 NM_004541 1.00 1.10 1.10 
NADH dehydrogenase 
(ubiquinone) 1 beta 
subcomplex, 1, 7kDa 
NDUFB1 NM_004545 1.00 0.88 1.16 
NADH dehydrogenase 
(ubiquinone) 1, 
subcomplex unknown, 1, 
6kDa 
NDUFC1 NM_001184986 1.00 1.03 1.12 
succinate dehydrogenase 
complex, subunit A, 
flavoprotein (Fp) 
SDHA NM_004168 1.00 0.98 1.42 (b) 
succinate dehydrogenase 
complex, subunit B, iron 
sulfur (Ip) 
SDHB NM_003000 1.00 0.91 1.34 (a) 
cytochrome c-1 CYC1 NM_001916 1.00 0.89 1.28 
ubiquinol-cytochrome c 
reductase core protein I 
UQCRC1 NM_003365 1.00 0.79 (c) 1.34 (b) 
ubiquinol-cytochrome c 
reductase core protein II 
UQCRC2 NM_003366 1.00 0.87 1.28 (a) 
cytochrome c oxidase 
subunit IV isoform 1 
COX4I1 NM_001861 1.00 0.85 1.23 
cytochrome c oxidase 
subunit IV isoform 2 
(lung) 
COX4I2 NM_032609 1.00 1.00 1.54 (b) 
ATP synthase, H+ 
transporting, 
mitochondrial F1 
complex, alpha subunit 1, 
cardiac muscle 
ATP5A1 NM_001001935 1.00 0.86 1.18 
ATPase, H+ transporting, 
lysosomal V0 subunit a2 
ATP6V0A2 NM_012463 1.00 1.04 1.08 
isocitrate dehydrogenase 
1 (NADP+), soluble 
IDH1 NM_005896 1.00 0.96 1.07 
isocitrate dehydrogenase 
2 (NADP+), mitochondrial 
IDH2 NM_002168 1.00 0.90 1.34 (a) 
malate dehydrogenase 1, 
NAD (soluble) 
MDH1§ NM_001199111 1.00 1.04 1.67 
malate dehydrogenase 2, 
NAD (mitochondrial) 
MDH2 NM_005918 1.00 0.79 0.98 
poly (ADP-ribose) 
polymerase 1 
PARP1 NM_001618 1.00 0.96 0.97 
poly (ADP-ribose) 
polymerase 2 
PARP2 NM_001042618 1.00 0.86 1.05 
K(lysine) 
acetyltransferase 2A 
KAT2A NM_021078 1.00 1.11 1.12 
K(lysine) 
acetyltransferase 2B 
KAT2B NM_003884 1.00 1.03 0.90 
Name Abbreviation Refseq # YG OG OT 
nuclear receptor 
coactivator 1 
NCOA1 NM_003743 1.00 1.09 1.04 
nuclear receptor 
coactivator 3 
NCOA3 NM_001174087 1.00 0.96 0.92 
nuclear receptor 
subfamily 1, group D, 
member 2 
NR1D2 NM_001145425 1.00 0.99 0.66 (b) 
estrogen receptor 1 ESR1 NM_000125 1.00 0.71 0.82 
estrogen receptor 2 (ER 
beta) 
ESR2 NM_001040275 1.00 2.28 2.54 
E1A binding protein p300 EP300 NM_001429 1.00 0.96 0.94 
CREB binding protein CREBBP NM_001079846 1.00 0.96 0.74 
cyclin-dependent kinase 
inhibitor 1A (p21, Cip1) 
CDKN1A NM_000389 1.00 2.34 1.62 
tumor protein p53 TP53 NM_000546 1.00 1.03 1.12 
Note: YG = young; OG = old; OT = old highly active. Data are expressed as fold change from the YG group. Full names and 
abbreviations of each gene are included along with the manufacturers Refseq #.   
(a) significantly different from OG, (b) significantly different from OG and YG, (c) significantly different from YG, (d) significantly
different from YG and OT, §main effect.
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